Biotech pauses trial after second patient death linked to gene therapy - The Washington Post
Last Updated: 19.06.2025 12:59
Biotech firm Sarepta Therapeutics said that a second patient died after receiving its gene therapy to treat Duchenne muscular dystrophy, the latest drug to draw scrutiny after winning fast regulatory… [+4788 chars]